↓ Skip to main content

Dove Medical Press

Difference in Gastrointestinal Risk Associated with Use of GLP-1 Receptor Agonists: A Real-World Pharmacovigilance Study

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, January 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
2 news outlets

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
23 Mendeley